TIAZOLO [4,5-C]CHINOLINE, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LE CONTENGONO

The invention relates to new thiazolo[4,5-c]quinoline derivatives of the general Formula I (I) and acid addition salts thereof, a process for the preparation of the same and pharmaceutical compositions comprising the said compounds. The substituent definition of the general Formula I is as follows:...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BERTA KNOLL, ILDIKO NIKLYA, GABRIELLA ZSILA, ATTILA MANDI, KATALIN BUDAI SIMONYI, JULIA TIMAR, LUJZA PETOCZ, EDIT BERENYI POLDERMANN, ZSUZSA FURTS, JOZSEF KNOLL
Format:	Patent
Sprache:	ita
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to new thiazolo[4,5-c]quinoline derivatives of the general Formula I (I) and acid addition salts thereof, a process for the preparation of the same and pharmaceutical compositions comprising the said compounds. The substituent definition of the general Formula I is as follows: R stands for hydrogen; a straight or branched chained alkyl group having 2-5 carbon atoms optionally substituted by one or more halogen atom(s); phenyl or phenyl-(lower alkyl) optionally bearing one or more substituent(s) on the phenyl ring; R1 and R2 are identical or different and stand for hydrogen, halogen or lower alkyl). The compounds of the general Formula I possess valuable central nervous depressive properties.